WallStreetZenWallStreetZen

NASDAQ: MDXG
Mimedx Group Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Mimedx Group revenue was $393.44M for the trailing 12 months ending Sep 30, 2025, with -55.6% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $113.7M, up 15.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MDXG annual revenue was $348.9M, with 8.5% growth year-over-year.

MDXG past revenue growth

How has MDXG's revenue growth performed historically?

Company
14.77%
Industry
150.01%
Market
20.37%
MDXG's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDXG's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDXG's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDXG revenue history

Current Revenue
$393.4M
Current Earnings
$40.8M
Current Profit Margin
10.4%
MDXG's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when MDXG announces revenue.

MDXG Revenue History By Year

MDXG Yearly RevenueMDXG RevenueMDXG ChangeMDXG Revenue Growth
2024-12-31$348.88M$27.40M+8.52%
2023-12-31$321.48M$53.64M+20.03%
2022-12-31$267.84M$25.82M+10.67%
2021-12-31$242.02M-$6.22M-2.50%
2020-12-31$248.23M-$51.02M-17.05%
2019-12-31$299.26M-$59.86M-16.67%
2018-12-31$359.11M$37.97M+11.82%
2017-12-31$321.14M$76.12M+31.07%
2016-12-31$245.02M$57.72M+30.82%
2015-12-31$187.30M$69.07M+58.43%
2014-12-31$118.22M$59.04M+99.77%
2013-12-31$59.18M$32.13M+118.76%
2012-12-31$27.05M$19.29M+248.60%
2011-12-31$7.76M$6.97M+883.74%
2010-12-31$788.87kN/AN/A
2009-03-31$0.00N/AN/A
2008-03-31$0.00N/AN/A
2007-12-31$0.00N/AN/A
2006-12-31$0.00N/AN/A

1 of 2

Mimedx Group Revenue FAQ

What was MDXG's revenue last quarter?

On Invalid Date, Mimedx Group (NASDAQ: MDXG) reported Q3 2025 revenue of $113.73 million up 35.3% year over year. In the same quarter last year, Mimedx Group's revenue was $84.06 million.

What was Mimedx Group's revenue in 2024?

Mimedx Group's annual revenue for the twelve months ending Dec 31, 2024 was $348.88 million, a 8.52% increase year over year.

How much does Mimedx Group make in a day?

Based on Mimedx Group annual revenue for the past five years, MDXG makes an average of $782,712.33 per day.

What was Mimedx Group's annual revenue growth in the past year?

As of Q4 2025, Mimedx Group's revenue has grown 14.77% year over year. This is 135.23 percentage points lower than the US Biotechnology industry revenue growth rate of 150.01%. Mimedx Group's revenue in the past year totaled $393.44 million.

How much does Mimedx Group make in a year?

Mimedx Group's revenue by year for the past five years is:
  • Mimedx Group's revenue for the twelve months ending Dec 31, 2024 was $348.88 million, a 8.52% increase year over year.
  • Mimedx Group's annual revenue for Dec 31, 2023 was $321.48 million, a 20.03% increase from 2022.
  • Mimedx Group's annual revenue for 2022 was $267.84 million, a 10.67% increase from 2021.
  • Mimedx Group's annual revenue for 2021 was $242.02 million, a 2.5% decrease from 2020.
  • Mimedx Group's annual revenue for 2020 was $248.23 million, a 17.05% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.